Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

Elecsys

9 posts
RRoche
Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation
Read More

Roche’s Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer’s-related amyloid pathology

  • 2026-04-17
Rules out Alzheimer’s pathology in early stages to enhance diagnostic pathway efficiency Provides new opportunity to broaden access…
RRoche
Data show Roche’s sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks
Read More

Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis

  • 2026-04-16
F. Hoffmann-La Roche Ltd The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed…
RRoche
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
Read More

Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis

  • 2026-04-13
F. Hoffmann-La Roche Ltd The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed…
RRoche
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
Read More

Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis

  • 2026-04-13
The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed with relapsing remitting multiple…
RRoche
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
Read More

Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease

  • 2026-03-29
The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4…
RRoche
Roche secures CE mark for blood test to identify ApoE4 carriers
Read More

Roche secures CE mark for blood test to identify ApoE4 carriers

  • 2026-03-18
Roche Holding AG received CE Mark approval for its Elecsys Apolipoprotein E4 (ApoE4) biomarker test, an in vitro…
RRoche
Roche’s Elecsys pTau181 test gains CE Mark to rule out Alzheimer’s
Read More

Roche’s Elecsys pTau181 test gains CE Mark to rule out Alzheimer’s

  • 2026-03-04
Roche’s Elecsys pTau181 test has secured CE Mark approval, marking a development in ruling out Alzheimer’s disease. The…
RRoche
Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC
Read More

Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC

  • 2026-02-20
– Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with…
RRoche
Roche’s Gen 6 Troponin T test accurately diagnosing heart attacks
Read More

Roche’s Gen 6 Troponin T test accurately diagnosing heart attacks

  • 2026-02-18
Roche Holdings AG reported results from its TSIX study which demonstrated that its sixth-generation Troponin T test is…
Switzerland
www.europesays.com